Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 78
Filter
1.
Why is COVID life-threatening for some people? Genetics study offers clues.
Ledford, Heidi.
Nature ; 617(7962): 661-662, 2023 May.
Article in English | MEDLINE | ID: covidwho-2324354

Subject(s)
COVID-19 , Humans , SARS-CoV-2
2.
White House to tap cancer leader Monica Bertagnolli as new NIH director.
Kozlov, Max; Ledford, Heidi.
Nature ; 616(7958): 638-639, 2023 Apr.
Article in English | MEDLINE | ID: covidwho-2298172

Subject(s)
Federal Government , National Institutes of Health (U.S.) , Neoplasms , Research Personnel , United States , National Institutes of Health (U.S.)/organization & administration , National Institutes of Health (U.S.)/trends , Research Personnel/legislation & jurisprudence
3.
Researchers scramble as Twitter plans to end free data access.
Ledford, Heidi.
Nature ; 614(7949): 602-603, 2023 02.
Article in English | MEDLINE | ID: covidwho-2268180

Subject(s)
Access to Information , Research Personnel , Social Media , Information Dissemination , Social Media/economics , Social Media/trends , Time Factors
4.
COVID-vaccine results are on the way - and scientists' concerns are growing.
Mallapaty, Smriti; Ledford, Heidi.
Nature ; 586(7827): 16-17, 2020 10.
Article in English | MEDLINE | ID: covidwho-2185679

Subject(s)
Clinical Trials as Topic , Coronavirus Infections/prevention & control , Drug Approval/legislation & jurisprudence , Drug Industry , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Politics , Research Personnel , Safety , Viral Vaccines/adverse effects , COVID-19 , COVID-19 Vaccines , Clinical Trial Protocols as Topic , Clinical Trials as Topic/ethics , Clinical Trials as Topic/methods , Clinical Trials as Topic/standards , Coronavirus Infections/epidemiology , Disclosure , Drug Industry/ethics , Drug Industry/legislation & jurisprudence , Drug Industry/standards , Humans , Myelitis, Transverse/etiology , Pneumonia, Viral/epidemiology , Public Opinion , Research Personnel/psychology , Sample Size , United Kingdom , United States , United States Food and Drug Administration/legislation & jurisprudence , Viral Vaccines/standards
5.
Lisa McCorkell Long-COVID advocate
Ledford, Heidi.
Nature ; 612(7941):619, 2022.
Article in English | ProQuest Central | ID: covidwho-2185686
6.
Severe COVID could cause markers of old age in the brain.
Ledford, Heidi.
Nature ; 2022 Dec 05.
Article in English | MEDLINE | ID: covidwho-2151009
7.
Chloroquine hype is derailing the search for coronavirus treatments.
Ledford, Heidi.
Nature ; 580(7805): 573, 2020 04.
Article in English | MEDLINE | ID: covidwho-2133267

Subject(s)
Coronavirus Infections , Coronavirus , Adenosine Monophosphate/analogs & derivatives , Alanine/analogs & derivatives , Betacoronavirus , COVID-19 , Chloroquine , Humans , Pandemics , Pneumonia, Viral , SARS-CoV-2
8.
COVID vaccine hoarding might have cost more than a million lives.
Ledford, Heidi.
Nature ; 2022 Nov 02.
Article in English | MEDLINE | ID: covidwho-2096653
9.
Donated COVID drugs start flowing to poor nations - but can't meet demand.
Ledford, Heidi.
Nature ; 2022 Sep 15.
Article in English | MEDLINE | ID: covidwho-2028660
10.
Spate of polio outbreaks worldwide puts scientists on alert.
Ledford, Heidi.
Nature ; 609(7925): 20-21, 2022 09.
Article in English | MEDLINE | ID: covidwho-2016623

Subject(s)
Disease Outbreaks , Global Health , Poliomyelitis , Research Personnel , Disease Outbreaks/statistics & numerical data , Global Health/statistics & numerical data , Humans , Poliomyelitis/epidemiology , Poliomyelitis/virology , Poliovirus Vaccines
11.
Which COVID boosters to take and when: a guide for the perplexed.
Ledford, Heidi.
Nature ; 609(7925): 18-19, 2022 09.
Article in English | MEDLINE | ID: covidwho-2000858

Subject(s)
COVID-19 , Immunization, Secondary , COVID-19/immunology , COVID-19/prevention & control , COVID-19/virology , COVID-19 Vaccines/administration & dosage , COVID-19 Vaccines/immunology , Humans , Immunization, Secondary/methods , Time Factors
12.
Long-COVID treatments: why the world is still waiting.
Ledford, Heidi.
Nature ; 608(7922): 258-260, 2022 08.
Article in English | MEDLINE | ID: covidwho-1991543

Subject(s)
Antiviral Agents , COVID-19 Drug Treatment , COVID-19 , Antiviral Agents/therapeutic use , COVID-19/complications , COVID-19/virology , Humans , SARS-CoV-2/pathogenicity , Time Factors , Post-Acute COVID-19 Syndrome
13.
How does COVID-19 kill? Uncertainty is hampering doctors' ability to choose treatments.
Ledford, Heidi.
Nature ; 580(7803): 311-312, 2020 04.
Article in English | MEDLINE | ID: covidwho-1972558

Subject(s)
Betacoronavirus/pathogenicity , Clinical Decision-Making , Coronavirus Infections/drug therapy , Coronavirus Infections/immunology , Interleukin-6/antagonists & inhibitors , Pneumonia, Viral/drug therapy , Pneumonia, Viral/immunology , Steroids/adverse effects , Steroids/therapeutic use , Uncertainty , Antibodies, Monoclonal, Humanized/pharmacology , Antibodies, Monoclonal, Humanized/therapeutic use , Betacoronavirus/drug effects , Betacoronavirus/immunology , COVID-19 , Coronavirus Infections/mortality , Coronavirus Infections/pathology , Humans , Immunosuppressive Agents/pharmacology , Immunosuppressive Agents/therapeutic use , Interleukin-6/immunology , Macrophages/drug effects , Macrophages/immunology , Pandemics , Physicians/psychology , Pneumonia, Viral/mortality , Pneumonia, Viral/pathology , Randomized Controlled Trials as Topic , SARS-CoV-2 , Steroids/administration & dosage , Steroids/pharmacology , T-Lymphocytes/drug effects , T-Lymphocytes/immunology
14.
Mysterious child hepatitis continues to vex researchers.
Ledford, Heidi.
Nature ; 607(7917): 20-21, 2022 07.
Article in English | MEDLINE | ID: covidwho-1931357

Subject(s)
Hepatitis , Child , Hepatitis/epidemiology , Humans , Research Personnel
15.
Delta reinfection risk low among unvaccinated children.
Ledford, Heidi.
Nature ; 2022 Jun 29.
Article in English | MEDLINE | ID: covidwho-1908134
16.
How common is long COVID? Why studies give different answers.
Ledford, Heidi.
Nature ; 606(7916): 852-853, 2022 06.
Article in English | MEDLINE | ID: covidwho-1900462

Subject(s)
COVID-19 , COVID-19/complications , COVID-19/epidemiology , Humans , Reproducibility of Results , Post-Acute COVID-19 Syndrome
17.
Rise of drug-resistant TB is hidden in plain sight
Ledford, Heidi.
Nature ; 605(7910):417-418, 2022.
Article in English | ProQuest Central | ID: covidwho-1860317
18.
Coronapod: 'viral ghosts' support idea that SARS-CoV-2 reservoirs could be behind long COVID.
Baker, Noah; Ledford, Heidi.
Nature ; 2022 May 13.
Article in English | MEDLINE | ID: covidwho-1852396
19.
African clinical trial denied access to key COVID drug Paxlovid.
Ledford, Heidi; Maxmen, Amy.
Nature ; 604(7906): 412-413, 2022 04.
Article in English | MEDLINE | ID: covidwho-1773950

Subject(s)
COVID-19 , Clinical Trials as Topic , Africa , Drug Combinations , Humans , Lactams , Leucine , Nitriles , Proline , Ritonavir , SARS-CoV-2
20.
Can drugs reduce the risk of long COVID? What scientists know so far.
Ledford, Heidi.
Nature ; 604(7904): 20-21, 2022 04.
Article in English | MEDLINE | ID: covidwho-1764151

Subject(s)
COVID-19 Drug Treatment , COVID-19 , Physicians , COVID-19/complications , Humans , SARS-CoV-2 , Post-Acute COVID-19 Syndrome
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL